t0, confirmed. Bending Spoons released Q2 2026 results before the US cash open on 2026-08-13, with a conference call set for 8:00am ET (12:00Z), per StockTitan (tier medium, results-date notice). The company's own document, on the GlobeNewswire wire (tier high, primary, own dateline), confirms: revenue $704M (+126% YoY), diluted EPS $0.28 (+163% YoY), Adjusted EPS $0.46, FY2026 guidance of $2.78 to 2.82B revenue and $1.46 to 1.51B Adjusted Operating Income, and a balance sheet with net debt of $4.09B at 2.4x leverage. What that document does not contain: any analyst consensus figure. Every "beat" or "miss" framing below comes from press, not the company.

The day before, confirmed, already stale by today's window. Investing.com (tier medium, direct fetch) reports BofA Securities downgraded BSP to Underperform on August 12, 2026 at 8:40am, price target $39, on a debt-capacity argument: the then-price implied roughly $18B of future M&A capacity against only about $7B of additional debt room expected by year-end 2027. That call is a full trading day old going into today's print, its information is already in yesterday's tape.

Premarket, today, reported. At 8:12am ET, about 18 minutes before the open, Investing.com (tier medium) reported BSP only about 1.5% lower, with the FY2026 guidance midpoint ($2.80B) described as below a roughly $2.895B consensus and organic revenue growth reported at 3%. A near-identical account ran on Yahoo Finance (tier medium, named byline). Both are press comparisons to consensus, not company statements. A separate, lower-tier source, Hiive (tier low, timestamp unclear), put the premarket move at -8.08%, which does not reconcile with the -1.5% figure above. I cannot resolve that discrepancy and I am not filling it with a guess.

Cash session, task data. Open at 13:30Z printed 46.83 (-4.4% vs the 48.98 prior close), already reflecting the premarket print. By 13:48Z, eighteen minutes in, the stock was -12.7% from that open. By 16:00Z (roughly noon ET, mid session, explicitly not the close) it was -15.7% from open, -19.45% vs prior close, last 39.46.

The gap. Between the 8:12am ET premarket read (-1.5%) and the 16:00Z mid-session read (-19.45% vs prior close), I could not locate any second dated item, filing, analyst note, or wire story that accounts for the additional roughly 18 points of decline. No new 6-K, no dated target cut, no litigation, no credit action found in this pass. That silence is a finding, not a hole to paper over.

Already known, not today's news. The $1.29B Airtable acquisition and a EUR500M financing facility were both disclosed via SEC Form 6-K, EDGAR (tier high), on August 4 and July 28 respectively, more than a week before today, and the FY guidance issued today explicitly excludes further acquisitions per the release's own footnote.

Sizing it. Shares outstanding are roughly 635.22M and today's volume ran about 2.1M to 2.75M shares (stockanalysis.com, tier medium), in line with or below recent average, not a blowout print. Prior close to the 16:00Z read is roughly $6.0B of market cap. The one number that actually changed in a document today, the FY26 revenue guide, moved by about $95M at the midpoint, on the order of 0.4% of that cap loss.

My method is to size the confirmed information against the size of the move. Today's confirmed document contains a beat on the quarter just reported (revenue and EPS both up sharply, tier high) and a trim to FY2026 revenue guidance of about $95M at the midpoint (roughly 3.3%, per press comparison to consensus, tier medium since the release carries no consensus number itself). That is real, confirmed, and small. Nothing in the confirmed record justifies a $6B repricing on its own.

There is a second, softer strand worth real weight: organic revenue growth reported at 3% (press and transcript coverage, tier medium, not something I could read in the primary release language itself), meaning almost all of the 126% headline growth is bought, not organic. That rhymes with BofA's debt-capacity downgrade from the day before, and with the confirmed 2.4x leverage and $4.09B net debt in the release. If the market is repricing the whole M&A-funded growth story rather than one line item, that is a legitimate, if not fully primary-sourced, reason for a bigger move than a $95M guidance trim alone would explain.

Even granting that generously, the arithmetic does not close. Premarket at 8:12am ET, after the release and with the BofA thesis already a day old, was -1.5%. By the open it was -4.4%. Eighteen minutes into the session it was -12.7% from that open. By mid session it was -19.45% from prior close. I found no fresh, dated, confirmed item accounting for that second leg. Per my own method's step five, when the timeline goes quiet and the price keeps moving, the likely explanation is flow, not news, and that fits a stock that IPO'd about six weeks ago with thin, dispersed sell-side coverage and ordinary, not blowout, volume on the day. Thin order books in newly public names air-pocket on ordinary participation, that is a mechanical story, and mechanical drops are the textbook reversion case once the imbalance clears.

Score: confirmed information is small relative to the move, there is a real but only press-reported deceleration story adding genuine weight, and a meaningful fraction of the total decline has no traceable catalyst in what I could assemble. That lands this at 76, comfortably in overreaction territory but short of the mid-80s and up reserved for moves with essentially no confirmed information behind them, because there is a confirmed guidance cut and confirmed leverage and growth facts. Direction is long. I am sizing reversion to the mechanism, a partial retracement of the untraced second leg, not a full return to the open, because the guidance trim and organic-growth deceleration are real and likely durable.

In order of how much each one worries me:

The organic-growth-deceleration read (3% versus a 126% headline) is the strongest case against my own verdict. It is only press and transcript sourced here, not something I read in the primary document myself, but if it is accurate and durable, today's print did not just trim a guidance range, it confirmed exactly the structural weakness BofA flagged in writing the day before, a debt-funded acquisition machine now also short on organic growth to fall back on. That is a thesis-confirming print, not a surprise, and thesis-confirming prints do not reliably revert, they can be the start of a re-rating.

Six weeks of trading history is not enough to build a normal base rate for this name. Dispersed, immature sell-side coverage and a thin float mean today's level could be the market still finding a real price for a complicated, M&A-heavy roll-up, not a dislocation from a stable prior price. I could not confirm a lockup schedule either way, so I cannot rule out mechanical supply pressure I have not seen.

The missing-second-catalyst finding is an absence-of-evidence claim, and my search pass stopped at a fixed budget. It is possible a wire story, an analyst note, or live commentary from the earnings call itself moved the tape further and I simply did not find it. I am flagging that gap, not asserting the negative with certainty.

Volume running in line with average rather than an exhausted, panicked print looks more like informed selling than a pure liquidity air pocket, and informed selling is exactly the kind of move that does not neatly revert.